BSX monthly performance report
Check BSX's monthly returns, drawdown, and seasonality trends — updated every month.
BSX monthly report
—
Key takeaways
- Boston Scientific (BSX) closed November 2026 at $44.34, up 5.62% for the month and −57.76% over the trailing 12 months.
- Year-to-date, BSX is −53.50%, underperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading −18.37% versus its 200-day moving average ($54.32), a cautious technical signal.
- Over the past three years, BSX has underperformed the S&P 500 by −88.82%, with a relative strength index reading of 48.2.
- Win rate over the trailing 39 months stands at 59% — 23 positive months versus 16 negative months.
Boston Scientific ended November 2026 at $44.34, posting a monthly return of +5.62%. The S&P 500 returned −0.18% over the same window, leaving relative performance at +5.80%.
The current quarter stands at +1.58% (Q4 2026 (QTD)), while medium-term trend remains soft: price is −18.37% versus the 200-day moving average ($54.32).
Year-to-date, BSX is −53.50% against SPY +10.62%, a gap of −64.12%. The stock is currently −58.03% below its 52-week high, with maximum 3-year drawdown at −61.55%.
| Period | BSX | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.32% | −0.36% | +0.68% |
| 1 Week | +3.72% | +2.59% | +1.12% |
| 1 Month | +5.62% | −0.18% | +5.80% |
| 3 Months | −13.79% | −2.37% | −11.42% |
| 6 Months | −17.20% | +0.83% | −18.03% |
| YTD | −53.50% | +10.62% | −64.12% |
| 12 Months | −57.76% | +12.25% | −70.01% |
| 3 Years | −17.45% | +71.37% | −88.82% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jan 2025 | +14.60% |
| #2 | Aug 2024 | +10.71% |
| #3 | Jul 2026 | +9.49% |
| #4 | Jan 2024 | +9.43% |
| #5 | Nov 2023 | +9.18% |
| Rank | Month | Return |
|---|---|---|
| #1 | Mar 2026 | −18.35% |
| #2 | Feb 2026 | −17.83% |
| #3 | May 2026 | −16.14% |
| #4 | Jun 2026 | −11.65% |
| #5 | Sep 2026 | −9.63% |
| Quarter | Return |
|---|---|
| Q3 2025 | −9.11% |
| Q4 2025 | −2.34% |
| Q1 2026 | −34.19% |
| Q2 2026 | −31.98% |
| Q3 2026 | +2.27% |
| Q4 2026 (QTD) | +1.58% |
| Year | Return |
|---|---|
| 2023 | +24.94% |
| 2024 | +54.51% |
| 2025 | +6.75% |
| 2026 | −53.50% |
| Metric | Value |
|---|---|
| 52-Week High | $105.65 (2025-11-13) |
| 52-Week Low | $39.57 (2026-10-28) |
| Current Price | $44.34 |
| 200-Day Moving Average | $54.32 |
| Price vs 200DMA | −18.37% |
| 3-Year Maximum Drawdown | −61.55% (2026-10-07) |
| Current Drawdown from 52W High | −58.03% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 48.2 |
| 3-Year Excess Return vs S&P 500 | −88.82% |
| RS Peak | 153.1 (May 2025) |
| RS Trough | 43.8 (Oct 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was BSX's return for this report period?
BSX returned +5.62% in the latest monthly window ending 2026-11-13.
Has BSX outperformed SPY year to date?
YTD BSX: −53.50% vs SPY: +10.62%.
What is BSX's 12-month return?
−57.76% over the trailing 12 months.
Is BSX above or below its 200-day moving average?
Price is −18.37% versus 200DMA ($54.32).
What is the maximum drawdown in the 3-year window?
−61.55% on 2026-10-07.